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Background: The Logistic Clinical SYNTAX Score (SXscore) allows for an individualised prediction of 1-year mortality in patients undergoing 
contemporary percutaneous coronary intervention (PCI). It is composed of a ‘Core’ (SXscore, age, creatinine clearance & left ventricular ejection 
fraction) and ‘Extended’ Model (composed of an additional 6 clinical variables), and has previously been cross-validated (‘internal-external’ 
validation procedure), in 7 contemporary stent trials. The aim of the study was to validate the Logistic Clinical SXscore in the Acute Catheterization 
and Urgent Intervention Triage StrategY (ACUITY) Trial (n=2627), to confirm its generalizability in other patient types.
methods: One-year mortality predictions from the Core & Extended models were validated with respect to discrimination (separation of those with 
& without 1-year all-cause death) (concordance [c] statistics) and calibration (agreement between observed & predicted outcomes) (validation 
plots). Decision curve analyses, which incorporate the harms (false positives) and benefits (true positives) of using a risk score to make mortality 
predictions, were undertaken to objectively assess its clinical usefulness.
results: The median SXscore was 9.0 (IQR 5-16); 39.7% had 3-vessel disease; and 84.9% DES implantation. Validation plots confirmed a broad 
agreement between predicted & observed mortality risks. The Core & Extended Models demonstrated a substantial improvement in predictive 
(discriminative) ability for 1-year all-cause Death compared to the SXscore in isolation (c-statistics: SXscore 0.64, 95% confidence interval [CI] 
0.56-0.71; Core Model 0.74, 95% CI 0.66-0.79; Extended Model: 0.77, 95% CI 0.70-0.83). Decision curve analyses confirmed the progressive 
improvement in mortality predictions with the Extended Model vs. the Core Model vs. the SXscore.
conclusion: The Core & Extended Models of the Logistic Clinical SXscore more accurately predicted individual 1-year mortality compared to the 
anatomical SXscore, in patients presenting with non ST-segment elevation ACS. These findings support the use of this score to aid decision making 
on the most appropriate coronary intervention.
